Company Filing History:
Years Active: 2014
Title: Pol-Henri Guivarc'h: Innovator in Pharmaceutical Formulations
Introduction
Pol-Henri Guivarc'h is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative oral dosage forms. His work focuses on enhancing the efficacy and delivery of medications.
Latest Patents
Guivarc'h holds a patent for a novel formulation of coated tablets. This patent discloses a pharmaceutically acceptable oral dosage form that includes fenofibrate, phospholipid, a buffer salt, and various bulking agents. The formulation is designed to improve the solubility and bioavailability of fenofibrate through the use of microparticles and a specialized matrix.
Career Highlights
Pol-Henri Guivarc'h is associated with Jagotec Ag, where he applies his expertise in pharmaceutical sciences. His innovative approach to drug formulation has positioned him as a key player in the industry. His work is characterized by a commitment to improving patient outcomes through advanced pharmaceutical technologies.
Collaborations
Guivarc'h collaborates with esteemed colleagues such as Michael G Vachon and Mishra K Awadhesh. These partnerships enhance the research and development efforts at Jagotec Ag, fostering an environment of innovation and excellence.
Conclusion
Pol-Henri Guivarc'h exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of drug delivery systems.